Relugolix 120mg tablets
BNF presentation 0803042X0AAAAAA within chapter Malignant Disease and Immunosuppression. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Presentation code
0803042X0AAAAAA
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
179
NHS spend (£)
£18,192.71
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 142 |
| February 2025 | 1 |
| December 2024 | 4 |
| November 2024 | 18 |
| October 2024 | 11 |
| August 2024 | 1 |
| July 2024 | 2 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 9 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 3 | No data available |
|
Buxted Medical Centre
ODS G81102
|
3 | 97R - SUSSEX ICB |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 3 | No data available |